Here's what we'll cover
Here's what we'll cover
What Jelly Roll Actually Said About Ozempic
Jelly Roll, the country and rap star whose legal name is Jason DeFord, weighed about 540 pounds at his heaviest. He finished 2025 at 265 pounds, a loss of roughly 275 pounds, according to his January 2026 cover story in Men's Health.
Because the loss was so dramatic, many people assumed he was on Ozempic. His answer is more nuanced than a flat denial. He said he briefly tried weight loss medication for about two weeks at the very start, then stopped and changed his approach. In earlier interviews he also said he was not against Ozempic but worried about side effects like acid reflux.
Even with that clarification, online accusations that he relied on GLP-1 drugs have continued. In late August 2026, while guest hosting Jimmy Kimmel Live!, he ended up in a viral Ozempic conversation of his own when Leslie Mann described how Judd Apatow gained weight on the drug.
Why GLP-1 Rumors Attach to Almost Every Weight Loss Story
When someone loses a lot of weight in public, GLP-1 medications are now the default assumption. That is because drugs like Ozempic and Wegovy genuinely changed what is possible.
Semaglutide 2.4 mg, the dose in Wegovy, produced an average weight loss of about 15% over 68 weeks in the STEP 1 trial. Tirzepatide, the active ingredient in Mounjaro and Zepbound, produced about 21% average weight loss at its highest dose over 72 weeks in SURMOUNT 1.
But the shorthand that anyone who lost weight must be on a GLP-1 does a disservice to people who got there another way, and to the medications themselves, which are serious treatments with specific criteria for use.
What GLP-1 Medications Actually Do (and Who They Are For)
GLP-1 receptor agonists mimic a hormone your gut releases after eating. That hormone tells your brain you are full and slows how quickly food leaves your stomach. The result is less hunger and, over time, lower calorie intake.
These medications are approved for specific uses:
- Wegovy (semaglutide): FDA approved in 2021 for chronic weight management in adults with a BMI of 30 or higher, or 27 or higher with at least one weight related condition.
- Zepbound (tirzepatide): FDA approved in 2023 for the same population. It targets both GLP-1 and GIP receptors.
- Ozempic (semaglutide) and Mounjaro (tirzepatide): approved for type 2 diabetes, including cardiovascular risk reduction in adults with type 2 diabetes. Use for weight loss alone is off label.
None of these are quick fixes. They work gradually, usually require ongoing use to maintain results, and perform best alongside nutrition and activity changes.
How Jelly Roll Lost the Weight
His approach was not lifestyle alone in the simple sense. It was structured and medically supported.
Treating Food as an Addiction
Jelly Roll has spoken openly about past addictions, and he says he finally made progress when he treated his relationship with food the same way. That meant confronting the emotional roots of his eating, not just counting calories.
Nutrition Coaching
He worked with chef and sports nutritionist Ian Larios, who calculated his calorie and macronutrient targets. Larios has said there were many setbacks along the way before the weight stayed off.
Running
At the start, he said he could not walk a full mile in 30 minutes. He built up gradually and now runs regularly, including 5K races.
Medical Support
He also worked with a medical team and started testosterone therapy after testing showed low levels. Large weight loss at any scale benefits from monitoring of blood pressure, labs, and nutrition.
What This Means If You Are Considering a GLP-1
His story does not make GLP-1 medications less valid. Obesity involves hunger and fullness signals that often work against people who are trying hard. For many, a GLP-1 corrects enough of that imbalance to make behavior change stick.
If you have struggled despite real effort, that is not a personal failing. It may mean your biology needs more support than lifestyle changes alone can give.
How the Main Options Compare
| Medication | Active Ingredient | FDA Approved For | Average Weight Loss in Pivotal Obesity Trial | Dosing |
|---|---|---|---|---|
| Wegovy | Semaglutide 2.4 mg | Chronic weight management; cardiovascular risk reduction | About 15% at 68 weeks | Once weekly injection or daily pill |
| Zepbound | Tirzepatide | Chronic weight management; obstructive sleep apnea | About 21% at 72 weeks (15 mg) | Once weekly injection |
| Ozempic | Semaglutide | Type 2 diabetes; related heart and kidney risk reduction | Not studied as an obesity drug | Once weekly injection |
| Mounjaro | Tirzepatide | Type 2 diabetes; cardiovascular risk reduction in type 2 diabetes | Not studied as an obesity drug | Once weekly injection |
Trial averages are not guarantees. Individual results vary.
The Cost Reality Celebrity Stories Skip
Prices have changed a lot. Self pay Wegovy pens now cost $349 a month through NovoCare, and Zepbound vials cost $299 to $449 a month through LillyDirect, depending on dose. Commercially insured patients may pay much less with manufacturer savings cards, and eligible Medicare patients can get Wegovy or Zepbound for $50 a month through the Medicare GLP-1 Bridge.
Ways to lower your cost:
- Check manufacturer savings and self pay programs from Novo Nordisk and Eli Lilly.
- Compare telehealth providers, which often bundle visits and medication at lower prices.
- Ask your insurer whether your plan covers obesity medications and what prior authorization requires.
- Browse GLP-1 Coupons for current discounts.
Questions to Ask a Doctor Before Starting
- Do I meet the clinical criteria for a GLP-1 prescription?
- Which medication fits my health history best?
- What side effects should I expect, and how are they managed?
- How long will I likely need to stay on it?
- What happens if I stop?
- Does my insurance cover it, and if not, what are my options?
- What nutrition and exercise changes will help it work best?
No waiting list. No insurance needed.
Frequently Asked Questions
Did Jelly Roll use Ozempic to lose weight?
Mostly no. In his January 2026 Men's Health cover story, Jelly Roll said he briefly tried a weight loss medication early on but stopped after about two weeks. Most of his 275 pound loss came from nutrition coaching, running, treating food as an addiction, and medical support.
How much weight did Jelly Roll lose?
He weighed about 540 pounds at his heaviest and ended 2025 at about 265 pounds, a loss of roughly 275 pounds over several years.
Can you lose 275 pounds without weight loss medication?
Yes, though it is uncommon and usually requires sustained behavior change, medical supervision, and often professional nutrition support. Some people also pursue bariatric surgery at that scale. There is no single path that works for everyone.
Who qualifies for a GLP-1 weight loss prescription?
Generally adults with a BMI of 30 or higher, or 27 or higher with at least one weight related condition such as high blood pressure, type 2 diabetes, or sleep apnea. A licensed provider must review your full health history first.
How much do Wegovy and Zepbound cost now?
Self pay Wegovy pens cost $349 a month through NovoCare, with lower introductory pricing for some new patients. Zepbound vials cost $299 to $449 a month through LillyDirect depending on dose. Insurance, savings cards, and the Medicare GLP-1 Bridge can lower costs further for eligible patients.
Is tirzepatide more effective than semaglutide?
In separate pivotal trials, tirzepatide at its highest dose produced about 21% average weight loss versus about 15% for semaglutide 2.4 mg. Individual results vary, and the right choice depends on your health history and how you respond.
The Bottom Line: What Jelly Roll's Story Really Teaches
Jelly Roll's 275 pound loss is impressive whatever the method. The honest version of his story is not that he refused GLP-1 drugs. He tried one briefly, decided it was not for him, and built a structured plan with medical and nutrition support instead.
Some people succeed that way. Others need the biological support a GLP-1 provides to get traction at all. Both paths are legitimate, and neither is morally superior.
Where to Start on GLP-1.com
- Compare providers: Use our Best Providers guide to find GLP-1 prescribers.
- Understand your options: Read our guides to Ozempic, Wegovy, and Mounjaro.
- Lower your costs: Check GLP-1 Coupons for current savings.
Always consult your physician or a licensed healthcare provider before starting, stopping, or changing any medication or weight loss program.